U.S., April 1 -- ClinicalTrials.gov registry received information related to the study (NCT07504172) titled 'Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity' on March 20.
Brief Summary: Tirzepatide is one of the new medications for the treatment of obesity. In clinical research people treated with Tirzepatide have weight loss up to 21%. But there is only a little bit of research showing the effect of Tirzepatide in clinical practice.
In this retrospective observational study the investigators will evaluate the effectiveness of tirzepatide in routine clinical practice among adults with obesity in the Netherlands.The main questions it aims to answer are:
* How much weight do patients lose after six months...